As Walgreens goes private in a $10 billion buyout, experts weigh what private equity ownership could mean for pharmacy care.
Articles on Pharmacies
Displaying 1 - 20 of 25 articles
Pharmacies in the UK face significant cuts, so it’s perhaps not surprising that they sell many unevidenced lifestyle products.
Despite appearances, Australia’s pharmacies don’t much compete with each other. Many are commonly owned, especially those near each other. They are ripe for an ‘Uber’ moment.
Once available, Opill will be the most effective form of nonprescription birth control on the market. But you should still speak with your health care provider about any questions.
Shoplifting has been hyped as a driver of chain-store closures, but did these companies ever really understand urban environments in the first place?
Different shoppers have different priorities, but some shops and services are ranked as important across the board.
The price you pay at the pharmacy for your long-term medicines may effectively halve. But not all medicines or patients qualify.
The new over-the-counter pill is highly effective at preventing pregnancy but must be taken at the same time daily, which can be a limitation for some people.
With the approval of the first over-the-counter oral contraceptive, pharmacists stand to play an ever-increasing role in helping expand access to reproductive health care in the post-Roe era.
Some states already allow pharmacists to provide birth control to patients with a prescription. But FDA approval of an over-the-counter birth control pill could greatly expand access.
Making them pay is important but it’s not going to stop drugmakers from endangering public health.
An infectious disease doctor discusses the use, benefits and availability of a drug to prevent severe COVID-19.
Earlier detection and treatment of COVID-19 by health care providers in pharmacies could help prevent surges in infection rates and severe illness.
Thinking carefully about people’s health during and after disaster is crucial to building disaster resilience. Ensuring access to medicines is a core part of that goal.
The TGA gave low-dose cannabis sales without prescription the green light in February. But no product has jumped through all the regulatory hoops to market yet.
Side-effects for this unproven and potentially dangerous treatment range from vomiting and diarrhoea to seizures and a coma.
Community pharmacies and pharmacists are important resources in Australia’s vaccine rollout, and right now they’re being under-utilised.
A successful rollout isn’t just about the physical points where people can get the vaccinations. It’s also about having a trained workforce to administer them.
For many reasons, drug users are shifting from the use of conventional psychoactive drugs such as cannabis, cocaine and heroin to pharmaceutical drugs for non-medical purposes.
Look out for your elderly parents, family members, friends and neighbors. It could save their lives.
Top contributors
-
Clinical Associate Professor of Pharmacy Practice, Binghamton University, State University of New York
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Associate Professor of Health Policy and Management, University of Pittsburgh
-
Associate Professor of Pharmacy and Therapeutics, University of Pittsburgh
-
Lecturer Pharmacy Practice, University of Sydney
-
Associate Professor of Comparative Effectiveness and Outcomes Research, University of Connecticut
-
Consultant Senior Lecturer in Primary Health Care, University of Bristol
-
Postdoctoral Research Fellow, North-West University
-
Associate Dean for Clinical Affairs and Professor of Pharmacy and Medicine, University of Florida
-
Honorary Senior Research Fellow at the University of Sydney, Honorary Adjunct Research Fellow, Western Sydney University
-
Professor of Medicine and Chair of Clinical Pharmacology, University of Newcastle
-
Researcher, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University
-
Associate professor, University of Sydney
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Clinical pharmacologist, University of Newcastle